[Study by the Professional Organization of German Transfusion Physicians on epidemiology of HIV- and hepatitis infections in blood donors].
The frequency of the seromarkers of HIV, HCV, and HBV in the donor population from all donor centers in Germany became available from the multicenter study of the transfusion services. From these data the risk of virus transmission by blood products can be estimated at 1:1 million for HIV and 1:50,000 for HBV. For HCV, preliminary data indicate the risk for Germany in less than 1:20,000. The risk is even lower, with less than 1:200,000 when calculated from seroconversion data of a rural donor population. The safety of blood products has been very much improved due to the continuous donor selection over the last years and by the epidemiologic situation in Germany.